Skip to main content

editorial

. 1984 Sep;59(9):813–814. doi: 10.1136/adc.59.9.813

Sodium valproate and routine liver function tests.

PMCID: PMC1628698 PMID: 6435543

813

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Dowling S. J. Hepatitis A in three patients taking sodium valproate. Lancet. 1984 Apr 28;1(8383):963–964. doi: 10.1016/s0140-6736(84)92423-1. [DOI] [PubMed] [Google Scholar]
Jeavons P. M. Non-dose-related side effects of valproate. Epilepsia. 1984;25 (Suppl 1):S50–S55. doi: 10.1111/j.1528-1157.1984.tb05638.x. [DOI] [PubMed] [Google Scholar]
Moore J. R., Williams T. H., Talbot I. C., Tanner M. S. Heterozygous alpha 1-antitrypsin deficiency and valproate hepatotoxicity. Lancet. 1984 Jan 28;1(8370):221–221. doi: 10.1016/s0140-6736(84)92139-1. [DOI] [PubMed] [Google Scholar]
Schnabel R., Rambeck B., Janssen F. Fatal intoxication with sodium valproate. Lancet. 1984 Jan 28;1(8370):221–222. doi: 10.1016/s0140-6736(84)92140-8. [DOI] [PubMed] [Google Scholar]
Zimmerman H. J., Ishak K. G. Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology. 1982 Sep-Oct;2(5):591–597. doi: 10.1002/hep.1840020513. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES